Trump’s first day in office

We’ve all removed the “elect” from President Donald Trump, and now it’s time to find out what he plans to do. Among the unknowns: Who’s going to run the FDA? Will Trump keep Francis Collins on for the long term? And just how serious is he about policing drug prices? Today begins biopharma’s new reality of parsing the president’s every move in hopes of figuring out what’s in store.

Tom Price goes back on the stand

Tom Price, Trump’s pick to lead HHS, will go before the Senate Finance Committee on Tuesday. This is the real one: The committee will then vote to advance his nomination to the full Senate. Expect much of the same from last week’s hearing: Democrats trying to pin Price down on Obamacare and Medicare, Republicans reassuring people they won’t leave them out to dry as they repeal and replace the ACA.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy